Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Protective Immunity
100%
DNA Vaccine
100%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
100%
Immune Response
66%
Neutralizing Antibodies
66%
Expression Vector
66%
Severe Acute Respiratory Syndrome
66%
Antibody Response
33%
T Cells
33%
Mouse Model
33%
Lung
33%
Virus
33%
Viral Replication
33%
Order of Magnitude
33%
Transmembrane Domain
33%
Vaccination
33%
Plasmid DNA (pDNA)
33%
Vector Encoding
33%
CD4 Cells
33%
Enzyme-linked Immunosorbent Assay (ELISA)
33%
Immune Defense
33%
T-cell Mediated
33%
Antibody Titre
33%
Gene-based
33%
Spike Glycoprotein
33%
DNA Expression Vector
33%
DNA Immunization
33%
CD8 Cells
33%
Public Health Measures
33%
Immunology and Microbiology
Neutralization
100%
Expression Vector
100%
SARS Coronavirus
100%
DNA Immunization
100%
Immune Response
66%
Antibody Response
66%
Neutralizing Antibody
66%
Severe Acute Respiratory Syndrome
66%
Glycoprotein
33%
Mouse Model
33%
T Cell
33%
Viral Replication
33%
CD4
33%
CD8
33%
Antibody Titer
33%
Plasmid
33%
DNA Vaccination
33%
Spike
33%
Enzyme-Linked Immunosorbent Assay
33%
T Lymphocyte Antibody
33%
Virus
33%
Lung
33%